Femasys Announces Financial Results for Quarter Ended March 31, 2025, and Provides Corporate Update
Provided By GlobeNewswire
Last update: May 8, 2025
-- Company delivers on mission to transform women’s health with innovative solutions, including FemaSeed® for first-line infertility treatment and FemBloc® non-surgical permanent birth control (full system approval pending in Europe) --
Read more at globenewswire.comNASDAQ:FEMY (8/27/2025, 3:12:31 PM)
0.3514
-0.03 (-7.53%)
Find more stocks in the Stock Screener
FEMY Latest News and Analysis
